|
000
| 02032nam 2200301za 4500 |
|---|
| 001 | 9.834047 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107150342 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170502t20162017onc ob f000 0 eng d |
|---|
| 020 | |a978-0-660-08028-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-178/2017E-PDF |
|---|
| 245 | 00|aInfection prevention and control guidance for Middle East respiratory syndrome coronavirus (MERS-CoV) in acute care settings |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bPublic Health Agency of Canada, |c2016, c2017. |
|---|
| 300 | |aii, 21 p. |
|---|
| 500 | |aIssued also in French under title: Lignes directrices sur la prévention et le contrôle du coronavirus du syndrome respiratoire du Moyen-Orient (CoV-SRMO) dans les établissements de soins actifs. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Publication date: March 2016." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The Public Health Agency of Canada (the Agency) has developed this document to provide infection prevention and control guidance to healthcare organizations and healthcare workers (HCWs) for: management of patients presenting to acute care settings in Canada, who have travelled to an affected area and/or been in contact with someone who has travelled to an affected area, within 14 days before onset of illness; management of HCWs and inpatients who have been exposed to a symptomatic confirmed case of MERS-CoV infection; and management of asymptomatic HCWs and inpatients who are RT-PCR positive for MERS-CoV"--P. 1. |
|---|
| 692 | 07|2gccst|aRespiratory diseases |
|---|
| 692 | 07|2gccst|aPreventive medicine |
|---|
| 692 | 07|2gccst|aSafety measures |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |
|---|
| 775 | 08|tLignes directrices sur la prévention et le contrôle du coronavirus du syndrome respiratoire du Moyen-Orient (CoV-SRMO) dans les établissements de soins actifs |w(CaOODSP)9.834048 |
|---|
| 856 | 40|qPDF|s334 KB|uhttps://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-178-2017-eng.pdf |
|---|